Product image of Metformin Stada (Metformin Hydrochloride) supplied by GNH India

Metformin Stada

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformin Stada (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformin Stada, is a biguanide presented as an oral tablet for oral use. It improves glycemic control in adults with type 2 diabetes mellitus by decreasing hepatic glucose output and enhancing peripheral insulin sensitivity.

GNH India supplies Metformin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides full regulatory documentation to support global distribution.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformin Stada is a biguanide indicated for disorders of glucose metabolism, primarily type 2 diabetes mellitus.

  • Type 2 diabetes mellitus: improves glycemic control when used with diet and exercise.
  • Insulin resistance: enhances peripheral insulin sensitivity to lower blood glucose levels.
  • Hyperglycemia: reduces hepatic glucose production, decreasing fasting plasma glucose concentrations.

How It Works

  • Metformin Hydrochloride acts by activating AMP‑activated protein kinase (AMPK) in liver and muscle cells, which suppresses gluconeogenesis, increases peripheral glucose uptake, and improves insulin sensitivity. It also modestly reduces intestinal glucose absorption, contributing to overall lower blood glucose concentrations without stimulating insulin secretion.

Side Effects

Metformin Stada may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: frequent loose stools.
  • Abdominal discomfort: cramping or pain.
  • Metallic taste: transient alteration of taste perception.
  • Loss of appetite: reduced desire to eat.
  • Flatulence: increased intestinal gas.

Serious or Rare Side Effects

  • Lactic acidosis: rare but life‑threatening metabolic disturbance.
  • Severe hypoglycemia: especially when combined with insulin or sulfonylureas.
  • Vitamin B12 deficiency: may develop with long‑term therapy.
  • Hepatic dysfunction: rare liver enzyme elevations.
  • Skin rash: occasional allergic skin reactions.
  • Pancreatitis: very rare inflammation of the pancreas.

Precautions & Warnings

Metformin Stada requires careful patient assessment and monitoring to minimise risks.

  • Renal function: assess eGFR before initiating and periodically thereafter.
  • Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment.
  • Alcohol consumption: limit intake to reduce lactic acidosis potential.
  • Pregnancy: use only if potential benefit justifies the risk to the fetus.
  • Monitoring: check vitamin B12 levels periodically during long‑term therapy.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin Stada can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure.
  • Cimetidine: can increase metformin plasma concentrations.
  • Alcohol: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask symptoms of hypoglycemia.
  • Diuretics: can affect renal clearance of metformin.
  • ACE inhibitors or ARBs: monitor renal function and electrolytes.

Frequently Asked Questions

Metformin Stada is an oral biguanide medication used to improve blood sugar control in adults with type 2 diabetes mellitus. It works as part of a comprehensive treatment plan that includes diet, exercise, and other therapies as prescribed by a healthcare professional.

Metformin Hydrochloride reduces hepatic glucose production and increases peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK). This dual action lowers fasting plasma glucose and improves overall glycemic control without directly stimulating insulin secretion.

The appropriate dose of Metformin Stada is determined by the prescribing clinician based on the individual’s medical condition, renal function, and response to therapy. Dosage adjustments are made according to clinical guidelines and patient tolerance.

Metformin Stada should be used during pregnancy or lactation only if the potential benefit outweighs any possible risk to the fetus or infant. Healthcare providers evaluate each case individually and discuss safety considerations with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin Stada belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, and SGLT2 inhibitors in its mechanism of reducing hepatic glucose output and enhancing insulin sensitivity. It is often first‑line therapy because of its efficacy, low risk of hypoglycemia, and favorable impact on weight.

Metformin Stada should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Metformin Stada is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or other predisposing factors. Prompt medical attention is required if symptoms such as unexplained fatigue, muscle pain, or rapid breathing develop.

Metformin Stada is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and those receiving iodinated contrast media for imaging studies without appropriate renal monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT